KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Cash from Financing Activities (2016 - 2026)

Sabra Health Care REIT has reported Cash from Financing Activities over the past 16 years, most recently at $52.1 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 151.46% year-over-year to $52.1 million; the TTM value through Mar 2026 reached $194.1 million, up 173.92%, while the annual FY2025 figure was $40.8 million, 122.45% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was $52.1 million at Sabra Health Care REIT, up from -$100.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $206.2 million in Q3 2025 and troughed at -$196.1 million in Q1 2023.
  • A 5-year average of -$38.9 million and a median of -$46.4 million in 2024 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: surged 2164.31% in 2022 and later tumbled 978.33% in 2024.
  • Year by year, Cash from Financing Activities stood at -$13.5 million in 2022, then surged by 30.74% to -$9.4 million in 2023, then tumbled by 978.33% to -$101.0 million in 2024, then rose by 0.07% to -$100.9 million in 2025, then skyrocketed by 151.64% to $52.1 million in 2026.
  • Business Quant data shows Cash from Financing Activities for SBRA at $52.1 million in Q1 2026, -$100.9 million in Q4 2025, and $206.2 million in Q3 2025.